Abstract
A case showing reinforcement of the action of warfarin and potassium in a patient administered S-1 is reported.The patient was a 71-year-old man with left upper gingival cancer.He had ventricular tachycardia (VT), hypertrophic cardiomyopathy, and a cerebellar infarction.He underwent a pacemaker implantation, and was administered warfarin.After the operation, in mid-March 2010, he was administered with S-1 and warfarin. However, the international normalized ratio of prothrombin time (PT-INR) increased to an extremely high level of 5.82, and S-1 and warfarin were stopped. They were re-administered at the end of April, and the PT-INR stabilized to approximately 2.
Publication types
-
Case Reports
-
English Abstract
-
Review
MeSH terms
-
Aged
-
Anticoagulants / therapeutic use*
-
Antimetabolites, Antineoplastic / therapeutic use
-
Cardiomyopathy, Hypertrophic / complications
-
Cardiomyopathy, Hypertrophic / drug therapy*
-
Cerebral Infarction / complications
-
Cerebral Infarction / drug therapy*
-
Drug Combinations
-
Drug Interactions
-
Humans
-
Male
-
Mouth Neoplasms / complications
-
Mouth Neoplasms / drug therapy*
-
Neoplasms, Squamous Cell / complications
-
Neoplasms, Squamous Cell / drug therapy*
-
Oxonic Acid / therapeutic use
-
Tachycardia, Ventricular / complications
-
Tachycardia, Ventricular / drug therapy*
-
Tegafur / therapeutic use
-
Warfarin / therapeutic use*
Substances
-
Anticoagulants
-
Antimetabolites, Antineoplastic
-
Drug Combinations
-
S 1 (combination)
-
Tegafur
-
Warfarin
-
Oxonic Acid